BiotechnologyManaged AI Agents
Biotechnology AI Agents,
Monitored for Integrity
Nestack Agent Care helps biotech organizations monitor, evaluate, and optimize AI agents used for research analysis, protocol drafting, data management, and trial operations — before small AI errors become integrity or compliance failures.
Scope
Biotechnology AI agents we build & manage
AI agents designed for research, clinical operations, safety, regulatory affairs, quality and GMP, research governance, manufacturing, and commercial workflows.
Research & lab6
Clinical & regulatory7
Drug safety4
Quality & manufacturing5
Observability
What we make observable
Every biotechnology agent session is traced across ten layers — what we capture and the evidence we keep.
- Evidence we keepGoalconstraintsapproval requirement
- Evidence we keepSourceversiontimestamprelevancecitation
- Evidence we keepPlanned sequenceactual sequenceworkflow status
- Evidence we keepTask statusresultretryfailure reason
- Evidence we keepTool nameversioninputoutputpermissionresult
- Evidence we keepModel/versioninput/outputtoken usagelatencycost
- Evidence we keepEvaluation typemetricthresholdresult
- Evidence we keepGuardrail targettriggeractionenforcement result
- Evidence we keepReviewerdecisioncorrectionreason
- Evidence we keepOutcome statusbusiness resultlinked trace
Catalog
Failure modes
Filter failure modes by where they occur in the agent lifecycle—from goals and retrieval to tools, evaluations, guardrails and outcomes.
BIO-01Protocol hallucination — concentrations, temperatures, timings, reagentsSEV-1
BIO-02Biosafety guidance errors — containment levels, spill response, wasteSEV-1
BIO-03IP / trade-secret leakage — sequences, constructs, unpublished resultsSEV-1
BIO-04Literature miscitation — wrong findings attributed to real papersSEV-2
BIO-05Trial-data transcription errorsSEV-1
BIO-06Regulatory-submission format/content errorsSEV-2
BIO-07Dual-use boundary violations — synthesis routes, enhancement queriesSEV-1
BIO-08Sample-tracking mismatches — LIMS IDs, chain of custodySEV-2
BIO-09Statistical and bioinformatics analysis errors — wrong test, batch effects, p-hackingSEV-2
BIO-10Adverse-event under-reporting — SAE not flagged or escalatedSEV-1
BIO-11Consent and protocol-deviation errors — IRB scope, eligibility, versioningSEV-1
BIO-12Cold-chain and reagent-stability errors — temperature, expiry, excursionsSEV-2
BIO-13Concentration and dilution conversion errors — molarity, dosing, unit mix-upsSEV-2
BIO-14Data-integrity documentation failures — ALCOA+, records, audit trailSEV-2
BIO-15Gene-symbol and identifier corruption — Excel autocorrect, HGNC nomenclature drift, accession manglingSEV-2
BIO-16Biosecurity sequence-screening evasion — functional homologs, split synthesis ordersSEV-1
BIO-17Cell-line misidentification — unauthenticated or cross-contaminated linesSEV-2
BIO-18Clinical variant misclassification — ACMG/AMP criteria, VUS vs. pathogenicSEV-1
BIO-19Guide-RNA and off-target design errors — specificity score, PAM, genome buildSEV-2
BIO-20Pharmacovigilance coding errors — MedDRA terms, E2B(R3) format, dictionary versionSEV-2
BIO-21Batch-record and deviation-review errors — completeness, CAPA closure, dispositionSEV-1
BIO-22Patient re-identification and PHI / genomic-data leakageSEV-1
BIO-23Indirect prompt injection via ingested documents and tool outputsSEV-1
BIO-24Trial blinding and randomization-integrity breaches — accidental unblindingSEV-1
BIO-25Export-control and select-agent governance errors — deemed exports, EAR, FSAPSEV-1
BIO-26Assay QC misinterpretation — Westgard rules, OOS/OOT, out-of-control runsSEV-2
A · Research-literature copilots
LR-01Retraction arrives after the copy01 · SearchSEV-1
LR-02Strategy will not rerun01 · SearchSEV-3
LR-03Preprint status lost in the pack02 · ScreeningSEV-2
LR-04Source does not carry the claim03 · ExtractionSEV-1
LR-05Wrong arm or timepoint extracted03 · ExtractionSEV-2
LR-06Safety report left in the pack04 · Pack / outputSEV-1
LR-07Corpus narrows between runs05 · Change / VersionSEV-3
B · Lab-protocol assistants
LP-01Drafted from a superseded version01 · Intake / retrievalSEV-1
LP-02Impacted document left off the list02 · ImpactSEV-2
LP-03Retraining not raised02 · ImpactSEV-2
LP-04Hazard or waste step not carried03 · DraftingSEV-1
LP-05Template sentence left in the method03 · DraftingSEV-2
LP-06Draft worked from as if effective04 · Pack / outputSEV-1
LP-07Silent drafting-rule regression05 · Change / VersionSEV-3
C · Clinical-trial support agents
TR-01Compared against a superseded protocol01 · Intake / retrievalSEV-1
TR-02Consent version not read at the visit01 · Intake / retrievalSEV-2
TR-03Deviation left off the list02 · ComparisonSEV-1
TR-04Query raised against data that is right02 · ComparisonSEV-3
TR-05Treatment-revealing value in a query03 · DraftingSEV-1
TR-06Safety signal handled as a data issue04 · Pack / outputSEV-1
TR-07Silent rule change moves the findings05 · Change / VersionSEV-3
D · Regulatory-submission helpers
RS-01Sequence history read short01 · Intake / retrievalSEV-1
RS-02Placed at the wrong node02 · PlacementSEV-2
RS-03Operation set on the wrong leaf02 · PlacementSEV-1
RS-04Validated on an old profile03 · ValidationSEV-3
RS-05Plan entry read as covered04 · Pack / outputSEV-1
RS-06Clock spent inside assembly04 · Pack / outputSEV-3
RS-07Granularity moves between sequences05 · Change / VersionSEV-2
E · LIMS / sample-tracking agents
LS-01Custody gap reads as a clean chain01 · Intake / loginSEV-1
LS-02Aliquot inherits the wrong parent01 · Intake / loginSEV-2
LS-03Excursion smoothed into a period mean02 · TrackingSEV-1
LS-04Reading outside limits raised as a query03 · AssessmentSEV-1
LS-05Cleaner repeat shown as the answer03 · AssessmentSEV-1
LS-06Record reads complete when it is not04 · File / handoffSEV-2
LS-07Limit changed outside change control05 · Change / VersionSEV-3
F · Pharmacovigilance case-processing agents
PV-01Day zero recorded late01 · Intake / receiptSEV-1
PV-02Case missed at intake01 · Intake / receiptSEV-1
PV-03Duplicate entered as new02 · Duplicate searchSEV-2
PV-04Verbatim coded too general03 · CodingSEV-1
PV-05Narrative outruns the source04 · Draft / writeSEV-2
PV-06Follow-up question never put04 · Draft / writeSEV-3
PV-07Silent convention change05 · Change / VersionSEV-2
G · Safety-signal-detection agents
SG-01Exposure that never fitted01 · Data assemblySEV-2
SG-02Smaller signal stays masked02 · Quantitative runSEV-1
SG-03Reporting surge read as risk02 · Quantitative runSEV-3
SG-04Indication read as effect03 · Evidence packageSEV-2
SG-05Ranked by alert, not by harm04 · Queue / outputSEV-1
SG-06Window spent in the tracker04 · Queue / outputSEV-1
SG-07Strata moved without a record05 · Change / VersionSEV-2
H · Medical-writing & CSR-authoring copilots
MW-01Drafted from a superseded lock01 · Intake / retrievalSEV-1
MW-02Output does not exist yet01 · Intake / retrievalSEV-3
MW-03Wording edges into interpretation02 · DraftingSEV-1
MW-04Narrative smoothed past the record02 · DraftingSEV-2
MW-05Right figure, wrong analysis set03 · Source checksSEV-2
MW-06Sections disagree with each other04 · Pack / outputSEV-1
MW-07Output rerun under a finished draft05 · Change / VersionSEV-2
I · GMP batch-record & release agents
GB-01Blank entry reads as complete01 · Intake / recordSEV-1
GB-02Paper insert never reaches the package01 · Intake / recordSEV-2
GB-03Reconciliation short, yield in range02 · CheckingSEV-2
GB-04Late entry passes as contemporaneous02 · CheckingSEV-1
GB-05Exception set narrows the review03 · ExceptionSEV-1
GB-06Deviation shows closed after reopening04 · PackageSEV-2
GB-07Rule change moves the exception line05 · Change / VersionSEV-3
J · Field-rep & pre-call commercial copilots
FP-01Opted-out prescriber planned against01 · Account pictureSEV-2
FP-02Access position out of date01 · Account pictureSEV-3
FP-03Expired piece selected02 · Content selectionSEV-2
FP-04Wrong market or audience02 · Content selectionSEV-2
FP-05Discussion point drifts off label03 · Plan draftingSEV-2
FP-06Event left in the commercial system04 · Record / hand-offSEV-1
FP-07Silent routing regression05 · Change / VersionSEV-1
K · Promotional-content review (MLR) agents
ML-01Superseded label version read01 · Label & referencesSEV-2
ML-02Reference does not say it02 · Claim checkingSEV-1
ML-03Annotated to the file, not the page03 · PresentationSEV-2
ML-04Thin fair balance read as adequate03 · PresentationSEV-1
ML-05Approved elsewhere, packaged here04 · Package / releaseSEV-1
ML-06Expiry passed while it waited04 · Package / releaseSEV-1
ML-07Silent check-rule regression05 · Change / VersionSEV-3
L · Autonomous-lab experimentation agents
AL-01Condition proposed outside the envelope01 · PlanningSEV-1
AL-02Optimiser chases an artefact01 · PlanningSEV-3
AL-03Run started on a lapsed calibration02 · PreconditionsSEV-2
AL-04Deck does not match the plate map02 · PreconditionsSEV-2
AL-05Incompatible work booked together03 · SchedulingSEV-1
AL-06Overnight failure raises nothing04 · ExecutionSEV-1
AL-07Manual intervention never recorded05 · Record / VersionSEV-2
M · Trial registration & results disclosure agents
EG-03Stale registry export01 · RetrievalSEV-3
EG-04Clock read from the wrong date02 · ReasoningSEV-1
EG-06Backstop lost behind a review02 · ReasoningSEV-1
EG-02Cure period never started03 · Tool / writeSEV-1
EG-05Three registers, three counts03 · Tool / writeSEV-2
EG-01Missing results element04 · OutputSEV-2
EG-07Silent clock drift05 · Change / VersionSEV-2
N · Deviation, CAPA & change-control agents
EH-03Prior events missed01 · RetrievalSEV-3
EH-04Scope stops at the batch02 · ReasoningSEV-1
EH-06Cause named as human error02 · ReasoningSEV-1
EH-02Clock started at creation03 · Tool / writeSEV-1
EH-05Effectiveness window early03 · Tool / writeSEV-2
EH-01Change filed nowhere04 · OutputSEV-2
EH-07Silent scope regression05 · Change / VersionSEV-2
O · Research-oversight & attestation evidence agents
EJ-03Superseded framework01 · RetrievalSEV-3
EJ-04Scope sweep too narrow02 · ReasoningSEV-1
EJ-06Amendment read as approved02 · ReasoningSEV-1
EJ-02Attestation never collected03 · Tool / writeSEV-1
EJ-05Person-level clock missed03 · Tool / writeSEV-2
EJ-01Flag ages in a queue04 · OutputSEV-2
EJ-07Silent scope drift05 · Change / VersionSEV-2
P · Aggregate safety report assembly agents
EM-03Scope read as current01 · RetrievalSEV-3
EM-04Denominators totalled02 · ReasoningSEV-1
EM-06Effectivity lag ignored02 · ReasoningSEV-1
EM-02Waiver applied family-wide03 · Tool / writeSEV-1
EM-05Assembled per programme03 · Tool / writeSEV-2
EM-01Reconciled to the database04 · OutputSEV-2
EM-07Silent template carry-forward05 · Change / VersionSEV-2
Q · Supplier, CMO & quality-agreement agents
ER-03Superseded register entry01 · RetrievalSEV-3
ER-04Auditing body misnamed02 · ReasoningSEV-1
ER-06Certificate read as current02 · ReasoningSEV-1
ER-02Notice clock never run03 · Tool / writeSEV-1
ER-05Agreement drifts from practice03 · Tool / writeSEV-2
ER-01Written assessment absent04 · OutputSEV-2
ER-07Silent currency regression05 · Change / VersionSEV-2
R · Out-of-specification investigation agents
ET-03Sequence not pulled01 · RetrievalSEV-3
ET-04Cause named too early02 · ReasoningSEV-1
ET-06Trend limits widen02 · ReasoningSEV-1
ET-02Clock started at entry03 · Tool / writeSEV-1
ET-05Retest count adjusted03 · Tool / writeSEV-2
ET-01Prior failure missed04 · OutputSEV-2
ET-07Silent checklist drift05 · Change / VersionSEV-2
S · Post-approval change & commitment agents
EW-03Superseded register row01 · RetrievalSEV-3
EW-04Milestone read as met02 · ReasoningSEV-1
EW-06One category, every market02 · ReasoningSEV-1
EW-02Guideline keyed to filing03 · Tool / writeSEV-1
EW-05Protocol read as standing03 · Tool / writeSEV-2
EW-01Two clocks, one register04 · OutputSEV-2
EW-07Silent milestone drift05 · Change / VersionSEV-2
T · Animal care & use protocol governance agents
EY-03Rescinded guidance01 · RetrievalSEV-3
EY-04Interval read as a quota02 · ReasoningSEV-1
EY-06Annual cycle enforced02 · ReasoningSEV-1
EY-02Amendment read as decided03 · Tool / writeSEV-1
EY-05Escalation list short03 · Tool / writeSEV-2
EY-01Finding without a date04 · OutputSEV-2
EY-07Silent interval drift05 · Change / VersionSEV-2
U · Safety labelling change & core data sheet agents
EZ-03Notification unowned01 · RetrievalSEV-3
EZ-04Pathway carried over02 · ReasoningSEV-1
EZ-06Extension not re-derived02 · ReasoningSEV-1
EZ-02Cascade misses a market03 · Tool / writeSEV-1
EZ-05Two versions translated03 · Tool / writeSEV-2
EZ-01Divergence unexplained04 · OutputSEV-2
EZ-07Silent matrix drift05 · Change / VersionSEV-2
V · Product quality review assembly agents
FA-03Register read as current01 · RetrievalSEV-3
FA-04Trend crosses a moved limit02 · ReasoningSEV-1
FA-06Conclusion filled in02 · ReasoningSEV-1
FA-02Pack issued unreconciled03 · Tool / writeSEV-1
FA-05Open item carried unchanged03 · Tool / writeSEV-2
FA-01Element left uncovered04 · OutputSEV-2
FA-07Silent element drift05 · Change / VersionSEV-2
Guardrails
Critical guardrails for Biotechnology agents
Ten controls that hold regardless of prompt, plan or pressure. Open one to see what it protects, what trips it, what the agent is forced to do, who may release it, and what is written to the record.
GR-01No lab protocol without verified concentration and reagent valuesOverride defined
Target
Generated lab protocols specifying concentrations, temperatures, timings, reagents and dilutions
Trigger
A protocol states a concentration, dilution or reagent value without a verified source
Action — enforced
Block the protocol and require verified values; agent may return a sourced protocol or flag for review
Human override
Released only by the responsible scientist after verifying values against the controlled protocol
Logged evidenceprotocol id · parameter · stated value · verified source · scientist identity · timestamp
GR-02No biosafety guidance below required containment levelOverride defined
Target
Containment, spill-response and waste-handling guidance for biological and hazardous materials
Trigger
Guidance specifies a containment level or spill response below the required biosafety standard
Action — enforced
Refuse the unsafe guidance and enforce the required containment; agent may direct to the biosafety officer
Human override
Released only by the biosafety officer confirming the containment level for the agent and task
Logged evidenceagent or material · proposed level · required level · officer identity · timestamp
GR-03No response advancing dual-use synthesis or screening evasionOverride defined
Target
Requests touching pathogen enhancement, synthesis routes and sequence-screening bypass techniques
Trigger
A query seeks enhancement, a synthesis route or a way to evade sequence screening
Action — enforced
Refuse the request and escalate per dual-use policy; agent may provide only non-actionable, published context
Human override
Released only by the institutional biosafety committee under documented dual-use review
Logged evidencequery id · dual-use category · refusal basis · escalation ref · reviewer identity · timestamp
GR-04No cross-program IP retrievalNo override
Target
Sequences, constructs, unpublished results and genomic data scoped to a single program or partner
Trigger
A request or tool call would read another program IP, partner data or patient genomes
Action — enforced
Deny the cross-program read and return only in-scope data; agent continues within the program boundary
Human override
None — cannot be overridden in session
Logged evidencerequesting program · target program · denied asset id · policy rule · timestamp
GR-05No instruction embedded in documents or tool outputs ever executedNo override
Target
Ingested papers, protocols, LIMS records and tool outputs the agent reads during a task
Trigger
Ingested documents or tool outputs contain directives or calls attempting to steer the agent
Action — enforced
Treat the content as data only and refuse the embedded instruction; the analysis task continues normally
Human override
None — cannot be overridden in session
Logged evidencesource id · detected instruction · artifact type · content hash · timestamp
GR-06No unescalated serious adverse eventOverride defined
Target
Safety-signal review of trial data, case reports and pharmacovigilance intake for adverse events
Trigger
Data indicates a serious adverse event yet it is not flagged or escalated for reporting
Action — enforced
Force the safety escalation and reporting workflow; agent may not downgrade and must preserve the signal
Human override
Released only by the pharmacovigilance officer after clinical review of the adverse-event signal
Logged evidencecase id · event term · seriousness · escalation route · officer identity · timestamp
GR-07No action risking unblinding or randomisation breachOverride defined
Target
Randomisation, allocation and blinding controls across the trial data and analysis pipeline
Trigger
An action would reveal allocation, break the blind or corrupt the randomisation sequence
Action — enforced
Block the action and preserve the blind; agent may continue on de-identified, allocation-masked data only
Human override
Released only by the unblinding statistician under the protocol-defined emergency-unblinding procedure
Logged evidencetrial id · subject id · requested action · blinding status · statistician identity · timestamp
GR-08No variant call without ACMG/AMP classification reviewOverride defined
Target
Clinical variant interpretation and reporting drawing on ACMG/AMP criteria and evidence
Trigger
A variant is reported as pathogenic or benign without a completed ACMG/AMP criteria review
Action — enforced
Hold the variant report and require criteria review; agent may return a documented classification with evidence
Human override
Released only by the clinical molecular geneticist confirming the ACMG/AMP classification and evidence
Logged evidencevariant id · genome build · classification · criteria applied · geneticist identity · timestamp
GR-09No trial record breaching ALCOA+ data integrityOverride defined
Target
GxP records the agent creates or edits, including trial-data transcription and audit trails
Trigger
A record write would transcribe data inaccurately or break the ALCOA+ audit trail
Action — enforced
Block the write and require source verification; agent may log a corrected, attributable entry with audit trail
Human override
Released only by the quality-assurance officer after verifying the record against source data
Logged evidencerecord id · source reference · before-and-after values · officer identity · timestamp
GR-10No batch disposition without completed deviation reviewOverride defined
Target
Batch-record disposition, deviation handling and CAPA closure for manufactured lots
Trigger
A batch is dispositioned with an open deviation, incomplete record or unclosed CAPA
Action — enforced
Hold the disposition and require review closure; agent may compile the record and route deviations for sign-off
Human override
Released only by the quality-assurance officer after deviation review and CAPA closure are complete
Logged evidencebatch id · open deviations · CAPA status · disposition · officer identity · timestamp
Oversight
Human review — triggers, decisions and evidence
When a defined risk trigger fires, the affected action is routed to a named reviewer. Every decision is recorded with its correction, escalation and final outcome for full traceability.
- ConfidenceLow-confidence variant call
- Financial impactHigh-value procurement
- Identity / change riskSample or cell-line identity
- Irreversible actionBatch release or submission
- Policy riskConsent or protocol deviation
- Safety controlGuardrail override
- Quality failureFailed critical evaluation
- Revieweridentity + role
- Decisionapprove / reject / amend
- Correctionwhat changed
- Escalationwho, why and severity
- Final outcomereleased / blocked / returned for rework
7 triggers · any one halts the agent
1 record · 5 fields, every time
Compliance
Regulatory mapping
- 01 Goal
- 02 Retrieval
- 03 Workflow
- 04 Task
- 05 Tool
- 06 LLM
- 07 Evaluation
- 08 Guardrail
- 09 Human review
- 10 Outcome
Adverse-event intake & expedited clocks
Fifteen calendar days run from the moment information qualifies, investigators report serious events immediately, and applicants must review adverse experiences from any source. Seriousness turns on outcome, not the term coded.
21 CFR 312.32(c)(1)(i) · 21 CFR 312.64(b) · 21 CFR 314.80(b)
Lifecycle layer:03 Workflow · 04 Task · 08 Guardrail · 10 Outcome
- BIO-10
- BIO-20
- LR-06
- TR-06
- PV-01
- PV-02
- PV-04
- PV-06
- FP-06
Evaluations
Baseline evaluation suite — in detail
Baseline evaluations are completed during onboarding and repeated based on the selected plan. Agents that fail critical checks remain restricted until they pass re-testing.
- Detailed case sets
- 82
- Failure modes covered
- 26
- Retired & rotated / quarter
- 10%
- Audit-ready scorecard
- Monthly
Output evaluation6 suites · 370 cases
150 casesProtocol groundingcatches BIO-01
100 casesCitation integritycatches BIO-04
100 casesData-transcription accuracycatches BIO-05
50 casesIP isolationcatches BIO-03
40 casesDual-use boundarycatches BIO-07
60 casesSubmission-format checkscatches BIO-06
70 casesAnalysis-method setcatches BIO-09
70 casesAdverse-event setcatches BIO-10
60 casesConsent and protocol setcatches BIO-11
60 casesCold-chain setcatches BIO-12
60 casesConcentration-conversion setcatches BIO-13
60 casesData-integrity setcatches BIO-14
60 casesBiosafety-guidance groundingcatches BIO-02
55 casesSample-tracking integritycatches BIO-08
60 casesGene-symbol integritycatches BIO-15
45 casesSequence-screening evasioncatches BIO-16
55 casesCell-line authenticationcatches BIO-17
70 casesVariant classificationcatches BIO-18
50 casesGuide-RNA off-target designcatches BIO-19
60 casesPharmacovigilance codingcatches BIO-20
60 casesBatch-record and deviation reviewcatches BIO-21
55 casesPatient re-identification / PHIcatches BIO-22
45 casesIndirect prompt injectioncatches BIO-23
55 casesTrial blinding integritycatches BIO-24
50 casesExport-control / select-agentcatches BIO-25
60 casesAssay QC acceptancecatches BIO-26
Use your work email to unlock the full grid. We use it to send the requested Agent Care material and qualify business inquiries. We do not sell or share your email.
Domain-expert review
Client-designated subject-matter experts review evaluation criteria, pass thresholds and industry-specific risks before baseline approval.
Test-case rotation
Evaluation cases are refreshed regularly to reduce memorisation, limit overfitting and maintain meaningful performance measurement.
Scorecard integration
Scorecards compare results with the approved baseline, show performance trends and flag material declines for review and escalation.
Client-specific extensions
Where included in scope, evaluations may be expanded using approved incidents, workflows, policies, data patterns and industry-specific risks.
Monitoring
Change-aware monitoring
When agent performance changes, Nestack correlates the shift with changes to the agent, prompt, model, tools, knowledge base, guardrails and evaluation suite.
- Week 1 · 98.7%
- Week 2 · 98.6%
- Week 3 · 98.8%
- Week 4 · 98.7%
- Week 5 · 98.9%
- Week 6 · 98.7%
- Week 7 · 98.8%
- Week 8 · 95.1%
- Week 9 · 94.9%
- Week 10 · 98.7%
- Week 11 · 98.8%
- Week 12 · 98.9%
Week readouthover or select
Week 8of 12
- 05Knowledge-basekb 2026.07
95.1%Protocol-grounding rate
- 7 layers stamped on every run · 12-week window
- Catches BIO-20 · dictionary-version coding errors
Something missing?
Don’t see your agent’s issue here?
Every AI environment is different. Share what you’re seeing, and we’ll review the behaviour, assess the risk and recommend the evaluations or controls that may help.
No commitment. Even if you never become a client, we’ll tell you what we think is happening.
Process
Universal incident runbook
Severity is assigned based on business impact, customer harm, data exposure, operational disruption and overall scope.
- SEV-1 Critical
- SEV-2 Major
- SEV-3 Moderate
- SEV-4 Minor
Automated monitoring or human review identifies unusual behaviour. Alerts are recorded and routed according to severity.
Outcomes
Not just that it ran.
What it delivered.
Observability shows the agent ran. It can’t show the batch was released or what the work cost. Where outcome data exists, we trace each result to its session — and a named reviewer signs off the month.
- Issued
- Monthly, per engagement
- Traced
- Every figure to its session
- Signed
- By your engagement reviewer
- Used for
- Client reporting, partner review, the AgentOps scorecard
Nestack AgentOps
Biotechnology fleet · monthly statement
- Protocol step verified5,280
- Batch record reviewed340
- Chain of custody closed1,960
- Adverse-event case processed118
- Study milestones completed9 of 9
- Workflows delivered7,698
- Outcome success rate98.9%
- Human correction required85 · 1.1%
Every figure linked to its source trace · exportable for review and audit support
Cost control
Keep biotechnology AI agent costs under control
Token spend is monitored, optimised and reported as part of Agent Care — and savings never come at the expense of quality, because every change is verified against your evaluation baseline.
We review token spend by agent, workflow, model, and session so you can understand where AI costs are coming from.
Running biotechnology AI agents in production?
Get a free assessment of one agent. We’ll review its behaviour, run a baseline evaluation and highlight potential risks and performance gaps.
Loading open times…
Open times
Select an available date above to view open 45-minute times from our calendar.
